Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
      EC 2.4.1
      EC 2.4.2
        EC 2.4.2.1
        EC 2.4.2.2
        EC 2.4.2.3
        EC 2.4.2.4
        EC 2.4.2.5
        EC 2.4.2.6
        EC 2.4.2.7
        EC 2.4.2.8
        EC 2.4.2.9
        EC 2.4.2.10
        EC 2.4.2.11
        EC 2.4.2.12
        EC 2.4.2.13
        EC 2.4.2.14
        EC 2.4.2.15
        EC 2.4.2.16
        EC 2.4.2.17
        EC 2.4.2.18
        EC 2.4.2.19
        EC 2.4.2.20
        EC 2.4.2.21
        EC 2.4.2.22
        EC 2.4.2.23
        EC 2.4.2.24
        EC 2.4.2.25
        EC 2.4.2.26
        EC 2.4.2.27
        EC 2.4.2.28
        EC 2.4.2.29
        EC 2.4.2.30
        EC 2.4.2.31
        EC 2.4.2.32
        EC 2.4.2.33
        EC 2.4.2.34
        EC 2.4.2.35
        EC 2.4.2.36
        EC 2.4.2.37
        EC 2.4.2.38
        EC 2.4.2.39
        EC 2.4.2.40
      EC 2.4.99
    EC 2.5
    EC 2.6
    EC 2.7
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.4.2.12 - nicotinamide- nucleotide:diphosphate phospho- β- D- ribosyltransferase (nicotinamide phosphoribosyltransferase)



3D structures of EC 2.4.2.12 - nicotinamide phosphoribosyltransferase in Protein Data Bank

updated: 6 January 2022, 2:15

In total: 74 PDB structures of EC 2.4.2.12 - nicotinamide phosphoribosyltransferase:
  1. 3g8e: Crystal Structure of Rattus Norvegicus Visfatin/pbef/nampt in Complex with an Fk866-based Inhibitor
  2. 3dkl: Crystal Structure of Phosphorylated Mimic Form of Human Nampt Complexed with Benzamide and Phosphoribosyl Pyrophosphate
  3. 3dkj: Crystal Structure of Human Nampt Complexed with Benzamide and Phosphoribosyl Pyrophosphate
  4. 3dhf: Crystal Structure of Phosphorylated Mimic Form of Human Nampt Complexed with Nicotinamide Mononucleotide and Pyrophosphate
  5. 3dhd: Crystal Structure of Human Nampt Complexed with Nicotinamide Mononucleotide and Pyrophosphate
  6. 3dgr: Crystal Structure of Human Nampt Complexed with Adp Analogue
  7. 6b76: Crystal Structure of Human Nampt in Complex with Nvp-lvr596
  8. 6b75: Crystal Structure of Human Nampt in Complex with Nvp-loq594
  9. 2e5b: Crystal Structure of Human Nmprtase as Free-form
  10. 2e5c: Crystal Structure of Human Nmprtase Complexed with 5'- Phosphoribosyl-1'-pyrophosphate
  11. 2e5d: Crystal Structure of Human Nmprtase Complexed with Nicotinamide
  12. 6azj: Crystal Structure of Human Nampt in Complex with Nvp-lqn520
  13. 6atb: Crystal Structure of Human Nampt in Complex with Nvp-lod812
  14. 2g95: Crystal Structure of Visfatin/pre-b Cell Colony Enhancing Factor 1/nicotinamide Phosphoribosyltransferase
  15. 2g96: Crystal Structure of Visfatin/pre-b Cell Colony Enhancing Factor 1/nicotinamide Phosphoribosyltransferase in Complex with Niconamide Mononucleotide
  16. 2g97: Crystal Structure of Visfatin/pre-b Cell Colony Enhancing Factor 1/nicotinamide Phosphoribosyltransferase in Complex with The Specific Inhibitor Fk-866
  17. 2gvg: Crystal Structure of Human Nmprtase and Its Complex with Nmn
  18. 2gvj: Crystal Structure of Human Nmprtase in Complex with Fk866
  19. 2gvl: Crystal Structure of Murine Nmprtase
  20. 2h3b: Crystal Structure of Mouse Nicotinamide Phosphoribosyltransferase/visfatin/pre-b Cell Colony Enhancing Factor 1
  21. 2h3d: Crystal Structure of Mouse Nicotinamide Phosphoribosyltransferase/visfatin/pre-b Cell Colony Enhancing Factor in Complex with Nicotinamide Mononuleotide
  22. 6tac: Human Nampt Deletion Mutant in Complex with Nicotinamide Mononucleotide, Pyrophosphate, and Mg2+
  23. 6ta2: Human Nampt in Complex with Nicotinic Acid Mononucleotide and Phosphate
  24. 6ta0: Human Nampt in Complex with Nicotinic Acid and Phosphoribosyl Pyrophosphate
  25. 6peb: Crystal Structure of Human Nampt in Complex with Nvp-ltm976
  26. 4jr5: Structure-based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (nampt) Inhibitors
  27. 4kfn: Structure-based Discovery of Novel Amide-containing Nicotinamide Phosphoribosyltransferase (nampt) Inhibitors
  28. 4kfo: Structure-based Discovery of Novel Amide-containing Nicotinamide Phosphoribosyltransferase (nampt) Inhibitors
  29. 4jnm: Discovery of Potent and Efficacious Urea-containing Nicotinamide Phosphoribosyltransferase (nampt) Inhibitors with Reduced CYP2C9 Inhibition Properties
  30. 6e68: Nampt Co-crystal with Inhibitor Compound 2
  31. 4kfp: Identification of 2,3-dihydro-1h-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  32. 4l4l: Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphoribosyltransferase
  33. 4l4m: Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphoribosyltransferase
  34. 4lts: Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (nampt) Inhibitors
  35. 4lv9: Fragment-based Identification of Amides Derived from Trans-2-(pyridin- 3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  36. 4lva: Fragment-based Identification of Amides Derived from Trans-2-(pyridin- 3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  37. 4lvb: Fragment-based Identification of Amides Derived from Trans-2-(pyridin- 3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  38. 4lvd: Fragment-based Identification of Amides Derived from Trans-2-(pyridin- 3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  39. 4lvf: Fragment-based Identification of Amides Derived from Trans-2-(pyridin- 3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  40. 4lvg: Fragment-based Identification of Amides Derived from Trans-2-(pyridin- 3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  41. 4lww: Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (nampt) Inhibitors
  42. 4m6p: Identification of Amides Derived from 1h-pyrazolo[3,4-b]pyridine-5- Carboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  43. 4m6q: Identification of Amides Derived from 1h-pyrazolo[3,4-b]pyridine-5- Carboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  44. 4n9b: Fragment-based Design of 3-aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  45. 4n9c: Fragment-based Design of 3-aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  46. 4n9d: Fragment-based Design of 3-aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  47. 4n9e: Fragment-based Design of 3-aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (nampt)
  48. 4o0z: Structural and Biochemical Analyses of The Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase
  49. 4o10: Structural and Biochemical Analyses of The Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase
  50. 4o12: Structural and Biochemical Analyses of The Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase
  51. 4o13: The Crystal Structure of Nampt in Complex with Gne-618
  52. 4o14: Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors
  53. 4o15: The Crystal Structure of a Mutant Nampt (S165F) in Complex with Gne- 618
  54. 4o16: Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors
  55. 4o17: Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors
  56. 4o18: Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors
  57. 4o19: The Crystal Structure of a Mutant Nampt (G217V)
  58. 4o1a: The Crystal Structure of The Mutant Nampt G217R
  59. 4o1b: The Crystal Structure of a Mutant Nampt (G217R) in Complex with an Inhibitor Apo866
  60. 4o1c: The Crystal Structures of a Mutant Nampt H191R
  61. 4o1d: Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors
  62. 4o28: Structural Basis for Resistance to Diverse Classes of Nampt Inhibitors
  63. 5wi1: Crystal Structure of Human Nampt with Fragment 5: (3e)-3- [(phenylamino)methylidene]oxan-2-one
  64. 5wi0: Crystal Structure of Human Nampt with Fragment 2: 2-[(2-fluorophenyl) Amino]-6-propylpyrimidin-4(3h)-one
  65. 5upf: Crystal Structure of Human Nampt with Isoindoline Urea Inhibitor Compound 53
  66. 5upe: Crystal Structure of Human Nampt with Isoindoline Urea Inhibitor Compound 5
  67. 5u2n: Crystal Structure of Human Nampt with A-1326133
  68. 5u2m: Crystal Structure of Human Nampt with A-1293201
  69. 5nsd: Co-crystal Structure of Nampt Dimer with Kpt-9274
  70. 5lx5: Crystal Structure of Visfatin in Complex with Sar154782-rp.
  71. 5lx3: Crystal Structure of Visfatin in Complex with Sar154782.
  72. 5kit: Crystal Structure of Nicotinamide Phosphoribosyltransferase (nampt) in Complex with Inhibitors 37
  73. 4wq6: The Crystal Structure of Human Nicotinamide Phosphoribosyltransferase (nampt) in Complex with N-(4-{(s)-[1-(2-methylpropyl)piperidin-4- Yl]sulfinyl}benzyl)furo[2,3-c]pyridine-2-carboxamide Inhibitor (compound 21)
  74. 7q8t: Crystal Structure of Nampt Bound to Ligand Tsy535(compound 9a)
© Copyright 2008-2009 by enzymes.me.uk